Order results by:
| Issue | Title | |
| Vol 19, No 2 (2026) | Biosimilar of the monoclonal antibody immunoglobulin G1κ daratumumab in treatment regimens for multiple myeloma patients | Abstract similar documents |
| M. M. Pankrashkina, A. L. Neverova, S. G. Malakho, E. S. Mikhailov, E. V. Naumova, E. I. Tikhonova | ||
| "... (ММ) лекарственным средством даратумумаб с учетом регистрации биоаналога оригинального препарата, а также возможности ..." | ||
| Vol 17, No 1 (2024) | Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients | Abstract similar documents |
| О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva | ||
| "... (ЛП) даратумумаб (Dara) к программе лечения «леналидомид + дексаметазон» (Rd) в ранних линиях терапии пациентов ..." | ||
| Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract similar documents |
| A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
| "... благодаря закупкам биоаналогов бевацизумаба и пембролизумаба, что позволило сэкономить 15,1 млрд руб ..." | ||
| Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
| A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
| "... референтных ЛП с истекающим сроком патентной защиты воспроизведенными копиями или биоаналогами в течение 5 лет ..." | ||
| Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract similar documents |
| D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
| "... альфа характеризуется экономией затрат в размере 24 420 руб. (32,37%) по сравнению с ФКД фоллитропина ..." | ||
| Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
| "... – 958 472 руб. (даратумумаб, 1–4 введения) в Волгоградской области. Возможными источниками ..." | ||
| 1 - 6 of 6 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
